Enhanced oral drug delivery by mimicking natural amino acid and oligopeptide absorption route DOI

Ruinan Wu,

Xiaoxing Fan, Licheng Wu

et al.

Nano Research, Journal Year: 2024, Volume and Issue: 18(2), P. 94907082 - 94907082

Published: Dec. 27, 2024

Language: Английский

Effects of kaempherol-3-rhamnoside on metabolic enzymes and AMPK in the liver tissue of STZ-induced diabetes in mice DOI Creative Commons
Alhussain Aodah, Faisal K. Alkholifi,

Khalid M. Alharthy

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: July 13, 2024

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia. It involves disturbances in carbohydrate, fat, and protein metabolism due to defects insulin secretion, action, or both. Novel therapeutic approaches are continuously being explored enhance control prevent complications associated with the disease. This study investigates potential of kaempherol-3-rhamnoside, flavonoid, managing diabetes modulating AMP-activated kinase (AMPK) pathway improving enzyme activities streptozotocin (STZ) -induced diabetic mice. Diabetic mice were treated varying doses kaempherol-3-rhamnoside and/or over 28-day period. Glycolytic gluconeogenesis liver, fasting blood glucose levels, serum lipid profiles oxidative stress markers assessed. Treatment significantly improved glycolytic activities, reduced glucose, enhanced levels compared controls. The compound also normalized suggesting its reversing dyslipidemia damage. Furthermore, activated AMPK pathway, indicating mechanism through which it could exert effects. Kaempherol-3-rhamnoside exhibits promising antidiabetic properties, potentially activation modulation. These findings support use as an adjunct therapy for management. Further clinical studies warranted validate these results human subjects.

Language: Английский

Citations

5

Lysine Potentiates Insulin Secretion via AASS-Dependent Catabolism and Regulation of GABA Content and Signaling DOI

Felipe Muñoz,

Qian Gao, Matthias Mattanovich

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2025, Volume and Issue: unknown

Published: March 3, 2025

Abstract Background and aim Lysine is an essential amino acid with insulinotropic effects in humans. In vitro , lysine also potentiates glucose-stimulated insulin secretion (GSIS) β cell lines rodent pancreatic islets. For decades it has been assumed that action of mediated by plasma membrane depolarization similar to arginine. Aminoadipate-Semialdehyde Synthase (AASS) a mitochondrial-located bifunctional enzyme engaged the first two steps catabolism. Whether AASS-dependent catabolism occurs cells whether required for its not investigated. Methods mRNA expression pathway genes was assessed human islets from non-diabetic (ND) type 2 diabetes (T2D) subjects. AASS silenced INS1 832/13 cells. metabolism function were investigated ELISA, extracellular flux analysis, live calcium imaging, transcriptomics metabolomics analyses. Results Expression involved catabolism, including AASS, ALDH7A1, DHTKD1 HADH reduced T2D donors. Silencing resulted lysine- Surprisingly, analysis Aass -KD suppressed identified γ-aminobutyric (GABA)/glutamate ratio as well altered implicated GABA metabolism. This accompanied mitochondrial TCA cycle oxidative phosphorylation (OXPHOS) activity, reflected elevated lactate/pyruvate whole-cell ATP/ADP content ATP-linked respiration. Glucose-and GABA-stimulated cytosolic Aass-KD Strikingly, addition recovered impaired Conclusion maintain adequate shunt signaling. addition, supports energy production, uptake secretion. Reduced may contribute depletion dysfunction patients.

Language: Английский

Citations

0

Miro1- a key player in β-cell function and mitochondrial dynamics under diabetes mellitus DOI

Srikanth Kavyashree,

Kannan Harithpriya, Kunka Mohanram Ramkumar

et al.

Mitochondrion, Journal Year: 2025, Volume and Issue: unknown, P. 102039 - 102039

Published: April 1, 2025

Language: Английский

Citations

0

Mitochondrial Bioenergetics in Physiology DOI
Martin Jastroch, Michaela Keuper

Acta Physiologica, Journal Year: 2025, Volume and Issue: 241(6)

Published: May 19, 2025

Language: Английский

Citations

0

Pancreatic islets undergo functional and morphological adaptation during development of Barth Syndrome DOI
Christopher Carlein, Markus D. A. Hoffmann, Andressa G. Amaral

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: July 2, 2024

Abstract Barth syndrome is a multisystem genetic disorder caused by mutation in TAFAZZIN , gene that encodes phospholipid:lysophospholipid transacylase important for cardiolipin remodeling. Syndrome patients suffer from number of symptoms including early heart failure, fatigue, and systemic metabolic alterations, hypoglycemia. The endocrine pancreas central to glucose homeostasis, however, the impact defective remodeling on pancreatic islet function consequences metabolism unclear. Surprisingly, mouse model with global knockdown, we observed improved tolerance compared wildtype littermates. We show secretory are robustly maintained through various compensatory mechanisms increased uptake mitochondrial volume. Transcriptomics analyses revealed expression genes encoding proteins involved N-acetylglucosamine synthesis protein O -linked N-acetylglucosaminylation. These pathways might provide molecular mechanism coupling changes volume regulation.

Language: Английский

Citations

0

Enhanced oral drug delivery by mimicking natural amino acid and oligopeptide absorption route DOI

Ruinan Wu,

Xiaoxing Fan, Licheng Wu

et al.

Nano Research, Journal Year: 2024, Volume and Issue: 18(2), P. 94907082 - 94907082

Published: Dec. 27, 2024

Language: Английский

Citations

0